1832 Asset Management
PFE icon

1832 Asset Management’s Pfizer PFE Stock Holding History

1832 Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-380,000
Closed -$16.6M – 952
2022
Q3 		$16.6M Hold
380,000
– – 0.03% 295
2022
Q2 		$19.9M Hold
380,000
– – 0.03% 274
2022
Q1 		$19.7M Buy
+380,000
New +$19.7M 0.03% 312

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

1832 Asset Management's PFE Position: Q2 2026 in Review

1832 Asset Management reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $780K and leaving 235,637 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #412.

1832 Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $472M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 1832 Asset Management held 235,637 shares of Pfizer worth $5.67M as of Q2 2026.
  • 1832 Asset Management sold 29,800 Pfizer shares in Q2 2026, an estimated $780K.
  • Pfizer made up ﹤0.01% of 1832 Asset Management's portfolio in Q2 2026, its #412 holding.
  • 1832 Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • 1832 Asset Management's Pfizer position peaked at $472M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.